Qi N. Cui

机构：Penn Presbyterian Medical Center, Tianjin Medical University Cancer Institute and Hospital, Zhongshan People's Hospital, Shijiazhuang Yiling Pharmaceutical (China), Huazhong University of Science and Technology · ORCID：0000-0002-5338-0401

发表论文 101 篇 · 总被引 1398 次 · h-index 20

代表论文

• Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium (2023 · Molecular Neurodegeneration · 被引 91)
• A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma (2024 · Cell · 被引 73)
• Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma (2023 · Frontiers in Cellular Neuroscience · 被引 36)
• Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change (2024 · American Journal of Ophthalmology · 被引 19)
• New Devices in Glaucoma (2023 · Ophthalmology and Therapy · 被引 16)
• Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic Retinopathy (2024 · Ophthalmic Epidemiology · 被引 15)